Logo image of ELES.MI

ELES SEMICONDUCTOR EQUIPMENT (ELES.MI) Stock Fundamental Analysis

Europe - BIT:ELES - IT0005373417 - Common Stock

2.27 EUR
-0.03 (-1.3%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

5

Overall ELES gets a fundamental rating of 5 out of 10. We evaluated ELES against 53 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and the financial health of ELES get a neutral evaluation. Nothing too spectacular is happening here. ELES is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ELES was profitable.
ELES had a positive operating cash flow in the past year.
In the past 5 years ELES has always been profitable.
ELES had a positive operating cash flow in 4 of the past 5 years.
ELES.MI Yearly Net Income VS EBIT VS OCF VS FCFELES.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

1.2 Ratios

With a Return On Assets value of 2.24%, ELES is not doing good in the industry: 77.36% of the companies in the same industry are doing better.
ELES's Return On Equity of 4.47% is on the low side compared to the rest of the industry. ELES is outperformed by 73.58% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.98%, ELES is in line with its industry, outperforming 45.28% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ELES is significantly below the industry average of 15.12%.
The last Return On Invested Capital (6.98%) for ELES is above the 3 year average (4.69%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROIC 6.98%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ELES.MI Yearly ROA, ROE, ROICELES.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of ELES (3.48%) is worse than 79.25% of its industry peers.
In the last couple of years the Profit Margin of ELES has declined.
ELES has a Operating Margin of 12.08%. This is comparable to the rest of the industry: ELES outperforms 41.51% of its industry peers.
In the last couple of years the Operating Margin of ELES has grown nicely.
With a decent Gross Margin value of 51.40%, ELES is doing good in the industry, outperforming 66.04% of the companies in the same industry.
In the last couple of years the Gross Margin of ELES has grown nicely.
Industry RankSector Rank
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
ELES.MI Yearly Profit, Operating, Gross MarginsELES.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELES is destroying value.
Compared to 1 year ago, ELES has more shares outstanding
ELES has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ELES has an improved debt to assets ratio.
ELES.MI Yearly Shares OutstandingELES.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ELES.MI Yearly Total Debt VS Total AssetsELES.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ELES has an Altman-Z score of 2.44. This is not the best score and indicates that ELES is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.44, ELES is doing worse than 73.58% of the companies in the same industry.
ELES has a debt to FCF ratio of 2.75. This is a good value and a sign of high solvency as ELES would need 2.75 years to pay back of all of its debts.
ELES's Debt to FCF ratio of 2.75 is in line compared to the rest of the industry. ELES outperforms 50.94% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that ELES is not too dependend on debt financing.
ELES's Debt to Equity ratio of 0.34 is on the low side compared to the rest of the industry. ELES is outperformed by 62.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Altman-Z 2.44
ROIC/WACC0.69
WACC10.04%
ELES.MI Yearly LT Debt VS Equity VS FCFELES.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

ELES has a Current Ratio of 2.33. This indicates that ELES is financially healthy and has no problem in meeting its short term obligations.
ELES has a Current ratio (2.33) which is in line with its industry peers.
A Quick Ratio of 1.79 indicates that ELES should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.79, ELES is in line with its industry, outperforming 58.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 1.79
ELES.MI Yearly Current Assets VS Current LiabilitesELES.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.37% over the past year.
Measured over the past 5 years, ELES shows a small growth in Earnings Per Share. The EPS has been growing by 0.68% on average per year.
Looking at the last year, ELES shows a quite strong growth in Revenue. The Revenue has grown by 8.92% in the last year.
Measured over the past years, ELES shows a quite strong growth in Revenue. The Revenue has been growing by 15.31% on average per year.
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%

3.2 Future

The Earnings Per Share is expected to grow by 45.70% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 13.61% on average over the next years. This is quite good.
EPS Next Y50%
EPS Next 2Y52.75%
EPS Next 3Y49.38%
EPS Next 5Y45.7%
Revenue Next Year13.89%
Revenue Next 2Y13.41%
Revenue Next 3Y13.69%
Revenue Next 5Y13.61%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ELES.MI Yearly Revenue VS EstimatesELES.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M
ELES.MI Yearly EPS VS EstimatesELES.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.05 0.1 0.15 0.2 0.25

6

4. Valuation

4.1 Price/Earnings Ratio

ELES is valuated quite expensively with a Price/Earnings ratio of 28.38.
Based on the Price/Earnings ratio, ELES is valued a bit cheaper than 60.38% of the companies in the same industry.
ELES's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
Based on the Price/Forward Earnings ratio of 24.73, the valuation of ELES can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as ELES.
When comparing the Price/Forward Earnings ratio of ELES to the average of the S&P500 Index (22.73), we can say ELES is valued inline with the index average.
Industry RankSector Rank
PE 28.38
Fwd PE 24.73
ELES.MI Price Earnings VS Forward Price EarningsELES.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELES is valued cheaper than 90.57% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ELES is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.6
EV/EBITDA 5.88
ELES.MI Per share dataELES.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

ELES's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ELES's earnings are expected to grow with 49.38% in the coming years.
PEG (NY)0.57
PEG (5Y)41.54
EPS Next 2Y52.75%
EPS Next 3Y49.38%

0

5. Dividend

5.1 Amount

ELES does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ELES SEMICONDUCTOR EQUIPMENT

BIT:ELES (9/5/2025, 7:00:00 PM)

2.27

-0.03 (-1.3%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.74%
Inst Owner ChangeN/A
Ins Owners31.74%
Ins Owner ChangeN/A
Market Cap39.02M
Analysts82.86
Price Target3.25 (43.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE 28.38
Fwd PE 24.73
P/S 1.09
P/FCF 6.6
P/OCF 6.2
P/B 1.4
P/tB 2.16
EV/EBITDA 5.88
EPS(TTM)0.08
EY3.52%
EPS(NY)0.09
Fwd EY4.04%
FCF(TTM)0.34
FCFY15.14%
OCF(TTM)0.37
OCFY16.13%
SpS2.08
BVpS1.62
TBVpS1.05
PEG (NY)0.57
PEG (5Y)41.54
Profitability
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROCE 10.95%
ROIC 6.98%
ROICexc 9.24%
ROICexgc 13.76%
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
FCFM 16.55%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ROICexc(3y)6.24%
ROICexc(5y)5.97%
ROICexgc(3y)9.41%
ROICexgc(5y)8.84%
ROCE(3y)7.35%
ROCE(5y)6.52%
ROICexcg growth 3Y38.04%
ROICexcg growth 5Y10.61%
ROICexc growth 3Y34.42%
ROICexc growth 5Y9.58%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
F-Score9
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Debt/EBITDA 1.27
Cap/Depr 12.67%
Cap/Sales 1.08%
Interest Coverage 250
Cash Conversion 85.52%
Profit Quality 475.3%
Current Ratio 2.33
Quick Ratio 1.79
Altman-Z 2.44
F-Score9
WACC10.04%
ROIC/WACC0.69
Cap/Depr(3y)32.99%
Cap/Depr(5y)27.08%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
EPS Next Y50%
EPS Next 2Y52.75%
EPS Next 3Y49.38%
EPS Next 5Y45.7%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%
Revenue Next Year13.89%
Revenue Next 2Y13.41%
Revenue Next 3Y13.69%
Revenue Next 5Y13.61%
EBIT growth 1Y38.54%
EBIT growth 3Y59.16%
EBIT growth 5Y29.31%
EBIT Next Year200%
EBIT Next 3Y58.14%
EBIT Next 5Y52.24%
FCF growth 1Y269.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.26%
OCF growth 3YN/A
OCF growth 5YN/A